Dr Lang Consulting GmbH brings 20 years of experience in pharmaceutical R&D, the successful development, manufacture and registration of biopharmaceutical drugs (focus on oncology and immunology).
Founder and Managing Director Dr. Markus A. Lang has profound leadership experience and successful P&L management of development portfolios in medium-sized companies as well as corporate environments in the biotech & pharmaceutical industry.
He made key contributions to successful development of several marketed drugs [Monjuvi®, Cyltezo®, Removab®, Pradaxa®]
As biotech entrepreneur Dr. Markus A. Lang supports companies in the areas of
- Venture Development
- C-Level Biotech Management. Organizational development
- Preparation & execution of fundraising campaigns
- Development and execution of drug development strategies
- Lifecycle Focus: Late Discovery through (early) Preclinical to Phase I IND Readiness and/or phase II PoCC
- Therapeutic entities: Biologics, ADCs and other moieties in primarily oncological and immunological disorders